Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 14 - Number 6

Sirtuins as Possible Drug Targets in Type 2 Diabetes

, 14(6): 622 - 636

Munehiro Kitada, Shinji Kume, Keizo Kanasaki, Ai Takeda-Watanabe and Daisuke Koya

DOI: 10.2174/1389450111314060002

Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience

, 14(6): 637 - 643

By Fabrizio Montecucco, Michele Cea, Inga Bauer, Debora Soncini, Irene Caffa, Denise Lasiglie, Aimable Nahimana, Antonio Uccelli, Santina Bruzzone and Alessio Nencioni

DOI: 10.2174/1389450111314060003

Sirtuin-1 and HIV-1: An Overview

, 14(6): 648 - 652

Marilia Rita Pinzone, Bruno Cacopardo, Fabrizio Condorelli, Michele Di Rosa and Giuseppe Nunnari

DOI: 10.2174/1389450111314060005

Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis

, 14(6): 676 - 699

Xiuming Xiong, Zhijian Xu, Zhuo Yang, Yingtao Liu, Di Wang, Mei Dong, Emily J. Parker and Weiliang Zhu

DOI: 10.2174/1389450111314060009

Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery

, 14(6): 708 - 722

Mahfoozur Rahman, Sarwar Beg, Mohammad Zaki Ahmad, Imran Kazmi, Aziz Ahmed, Ziyaur Rahman, Farhan Jalees Ahmad and Sohail Akhter

DOI: 10.2174/1389450111314060011


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog